Itzhak Goldberg - Dec 6, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Executive Chairman and Chief Scientific Officer, Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Itzhak Goldberg
Stock symbol
ELTX
Transactions as of
Dec 6, 2021
Transactions value $
-$107,721
Form type
4
Date filed
12/7/2021, 03:06 PM
Previous filing
Dec 3, 2021
Next filing
Jul 11, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale -$108K -32.1K -1.83% $3.35 1.72M Dec 6, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.21 to $3.45 inclusive.

Remarks:

Executive Chairman and Chief Scientific Officer